BUMC Research Town Meeting: Research Update Ronald B. Corley, Ph.D. Associate Provost for Research November 07, 2011
NIH Funding _________________________________ • NIH budget currently under continuing resolution (FY 11 – 1.5%) until November 18 • NIH budget for 2012 (still anyone’s guess) – Senate appropriations committee ‐ $30. 5 billion • decrease of $190 million, 0.6 % from FY 2011. • $20 million to authorize the Cures Acceleration Network at NIH • creates the National Center for Advancing Translational Sciences – House ‐ $31.7 billion • Increase of $1B, 3.3% (matches president’s request) • No mention of NCATS • Anticipate increased discussion of changes in policies for cost recovery (direct and indirect), salary cap, etc .
Grants and grants submissions _________________________________ Monthly list of foundation grants – we want • feedback: – Too late? 2 months? – Areas not covered? – Improving navigation: hyperlinks – Web page to catalogue by month? • Added an “Office of Proposal Development” – Director has been recruited (Renna Lilly) – Contact: rolilly@bu.edu; 8 ‐ 4502 – Will be housed on R7
Grants and grants submissions _________________________________ • New process for internally reviewing SIGs and SIG support (with Core Advisory Committee) – Build best case for need (and build compelling user base) – Space identification – Institutional support • Pre ‐ proposal form: www.bu.edu/cores/sigapp
Cores (www.bumc.bu.edu/cores; www.bu.edu/cores) _________________________________ • Centralization of cores (scheduling and billing software, administrative centralization for billing (Alexis Corazzini); developing reporting • Core Advisory Committee – Developing a process for review of existing cores – Beginning to review ideas for new cores: biostatistics/bioinformatics – Others? : proteomics/mass spec, enzyme bank on campus, sequencing, metabolomics, etc) ?
Cores (cont) _________________________________ • Review finances of all cores (underway) – understand existing subsidies and needs • Reviewing space utilization by cores – Consolidation of space (leveraging/sharing technical support) • Reviewing instrumentation needs – Purchased new Aria cell sorter (Flow Core) – Helped purchase Zeiss 710 NLO 32 channel multiphoton microscope (T Haydar, L8) – new core to increase our imaging capabilities
Update on LASC _________________________________ • Worked with LASC (Jim Levin) and ORC to establish and engage LASC animal user groups – discuss issues of importance to the users – rates and rate changes are aired • Discussions with MUAC ‐ ready to initiate re ‐ derivation of all colonies with questionable health status – Process defined – Discussing financial support and costs to investigators
LASC Update _________________________________ • Currently undergoing a space review (Jacobs Consulting) with particular attention to: – More functional mouse housing and procedure spaces – W7,8,9 and 670 – Design and build ‐ out of behavioral space – M9 – Increased space for USDA regulated species – Increased ABSL ‐ 2 space – Consolidation of instrumentation (imaging, etc.) – Design plan for new zebrafish facility – R8 (currently slated to be started in mid 2012)
www.bumc.bu.edu/expertise _________________________________
www.bumc.bu.edu/expertise _________________________________
www.bumc.bu.edu/expertise _________________________________ If you log in, you can also search the BU asset management site (to locate equipment)
Modifying Your Profile _________________________________ please uncheck these! Insert a research description if not prepopulated Insert or modify key words
_________________________________ Link to your website!
_________________________________ Description of Profiles Chris Shanahan
_________________________________ The Oral Cancer Research Initiative Maria Kukuruzinska
Research Web Site _________________________________ • www.bumc.bu.edu/research • Please send science photos, etc. • Please send suggestions to: aprbumc@bu.edu
BUMC Multidisciplinary Research Conference _________________________________ “Nano, Metabolic and Inflammatory Routes to Cardiovascular Disease” Wed, November 9, 3:30 ‐ 5 p.m. Hiebert Lounge
BUMC Research Town Meeting - 11/7/11 Profiles Research Networking Software Christopher Shanahan, MD MPH - Faculty Lead
Profiles RNS • What is it? • Why its important? • Who is using it? • How does it work? • How to make work for you.
Profiles RNS: Who, What, & Why? • Who is the sponsor? – CTSI – David Center, MD • Who benefits? – The BU Research community • What is it? – A powerful, user-friendly, social networking and expertise data-mining tool • Why use it? – Find potential collaborators & mentors – Add new expertise to your team – Reveal new directions for your research
Profiles RNS: When? (Adoption Plan) Phase 1: Advance Deployment (Nov 9) Phase 2: Go-Live (Dec 12) – Training & Resource material distribution – Faculty engagement campaign • e-mail • Unit presentations • Project website Phase 3 - Maintenance
Profiles RNS – Making it work for you Do Nothing • Basic Demographic / Contact data pre-entered • Publication Data updated automatically Make it even Better • For Others… – Refine your Profile ( Curation) • Add descriptions & other information • Review & update your publications • For Yourself … – Create, maintain, & monitor your private Network
Other Institutions using Profiles RNS VIVO – SciVal Experts – CTSI HUB Lattice Grid – CAP – Digital Vita - Loki
Name, Search Affiliation, & Contact Concepts Other Positions Menu Co- History Authors Mentoring Similar People Same Publications Dept. (List All or Timeline) Physical Neighbors
Questions?
Office of the Associate Dean for Research, GSDM 650 Albany Street (X-Bldg.), Room 343 Boston, MA 02118 http://www.bu.edu/dental-research/
Oral cancer is one of the most pernicious epithelial malignancies in the world, whose incidence is on the rise. Despite progress in diagnosis and treatment of oral cancer, the 5-year survival rates over the past twenty years have remained at about 50%. Oral cancer disproportionately affects underserved minorities in the US and in developing countries. The Oral Cancer Research Initiative (OCRI) is a focused multidisciplinary collaborative that brings together basic scientists, clinicians, public health researchers, engineers, chemists and computational biologists to work on diverse issues related to oral cancer. Our mission: to elucidate the mechanisms of oral cancer development and progression and to expedite translation of research findings toward diagnosis, prevention, treatment and cure of oral cancer. Our multidisciplinary effort will align research on oral cancer with societal needs.
Center for Global Health & Development B. Brown S. Buquor Genetics/ Biomedical Public Basic Clinical Translational Engineering Genomics Health Infection- Drivers & Biomarkers Metabolism Surgery Radiology Pathology Prevention Epidemiology Associated Pathways Stem Cells Cancers M. Kukuruzinska F. Oppenheim B. Corkey (M&CB) (P&OB) C. Genco S. Jalisi (High Throughput D. Bowen W. Cardoso G. Huang V. Noonan (BUSM, Microbio.) (BUSM, Surg. Onc.) Screening, (SPH) M. McClean (BUSM, Pulmonary) O. Sakai (Endodontics) (O&M Path.) D. Anderson P. Mehra Metabolism) J. Jones (SPH) P. Trackman (BUSM, Radiology) K. Applebaum Y. Wu (BUSM, Microbio.) (OMS) (BUSM, Medicine) (Gen. Dent., VA) K. Applebaum (P&OB) (SPH) (General Dentistry) K. Applebaum A. Salama N. Istfan (SPH) X. Varelas A. Spira (SPH) (OMS) (BUSM, (BUSM, Biochem.) (BUSM, Endocrinology) D. Seldin Computational (BUSM, Hem Onc) Biomedicine) S. Amar Clinical Research Center (CRC) (P&OB) D. Levin Evans Center for Interdisciplinary Biomedical Research (M&CB) Affinity Research Collaboratives (ARCs), BUSM (K. Ravid) M. Trojanowska (BUSM, Arthritis Center) CTSI W. Adams D. Fournier B. Goldberg A. Spira (Informatics/i2b2) (CTSI, Program M. Cabodi (BUSM, Computational R. Pistey J. Porco Evaluation) S. Unlu Biomedicine) (Biospecimen Archive (Center for Chemical M. Platt Research Core) Center for Nanoscience Methodology & Library (BUSM, Otolaryngology) & Nanobiotechnology Development) Office of Technology Development (OTD)
Recommend
More recommend
